News: In the world of finance, dividends play a crucial role. They are like little rewards that companies give to their shareholders. One such company that has caught our attention is Hikal Ltd. Let’s dive into the details of their 2024 dividend, including the record date, share price, and historical context.
Hikal Ltd is a pharmaceutical company that operates in India. They are involved in the production of various chemicals, active pharmaceutical ingredients (APIs), and crop protection products. As a publicly traded company, they have shareholders who invest in their growth and success.
For the financial year ending in March 2023, Hikal Ltd declared an equity dividend of 60.00%, which amounts to Rs 1.2 per share. This means that for every share you own, you would receive Rs 1.2 as a dividend.
The record date for the 2024 dividend is 20th February 2024. On this date, the company will determine who the eligible shareholders are. If you own Hikal Ltd shares on or before this date, you’ll be entitled to receive the dividend.
As of 8th February 2024, Hikal Ltd announced a dividend of Rs 0.6 per share. The current share price stands at Rs 294.10. Keep in mind that share prices can fluctuate based on market conditions, company performance, and other factors.
To understand the significance of this dividend, let’s take a quick look at Hikal Ltd’s dividend history. While we don’t have the complete historical data here, it’s essential to recognize that dividends reflect a company’s financial health and commitment to its shareholders. Regular dividends can attract investors and provide stability.
Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.
Hikal Ltd is a pharmaceutical company based in India. Established in 1988, it has become a reliable partner for various industries, including:
Hikal operates five manufacturing facilities across India, located in Maharashtra (Taloja and Mahad), Gujarat (Panoli), and Karnataka (Jigani). These facilities undergo regular inspections by multinational companies and global regulatory authorities.
Notably, Hikal is the first Indian life sciences company to receive the Responsible Care certification granted by the International Council of Chemical Associations (ICCA). This certification reflects their commitment to safety, health, and environmental protection.
Hikal serves a global clientele, providing world-class active ingredients, intermediates, and R&D services. Their enduring relationships with companies like Sumitomo Corporation, AgrEvo, Merck, and Novartis underscore their reputation in the industry.
Hikal Ltd’s 2024 dividend is a positive sign for shareholders. If you’re an investor, mark your calendar for the record date and keep an eye on the share price.
Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.
Note: All informations like net worths, obituary, web series release date, health & injury, relationship news & gaming or tech updates are collected using data drawn from public sources ( like social media platform , independent news agency ). When provided, we also incorporate private tips and feedback received from the celebrities ( if available ) or their representatives. While we work diligently to ensure that our article information and net worth numbers are as accurate as possible, unless otherwise indicated they are only estimates. We welcome all corrections and feedback using the button below.
Advertisement